A review of the bioactivity of beauvericin - a bioactive compound produced by fungi

Đoàn Mạnh Dũng, Trần Quang Huy

Nội dung chính của bài viết

Tóm tắt

Beauvericin is a well-known insecticidal, antibacterial, antiviral and cytotoxic mycotoxin with a cyclic hexadepsipeptide structure that is a piece of the enniatin antibiotic family. It could be applied in several fields such as insecticides and pharmaceuticals. Other aspects of beauvericin like the toxicity and the determination techniques were mentioned in previous reports but there are seldom published about the bioactivity. Therefore, this is the first review discussing some various bioactivities of the fungal substance beauvericin such as insecticidal activity, and antitumor activity.

Chi tiết bài viết

Tài liệu tham khảo

Calò, L., Fornelli, F., Ramires, R., Nenna, S., Tursi, A., Caiaffa, M. F., & Macchia, L. (2004). Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin. Pharmacological Research, 49(1), 73–77.
Champlin, F. R., & Grula, E. A. (1979). Noninvolvement of beauvericin in the entomopathogenicity of Beauveria bassiana. Applied and Environmental Microbiology, 37(6), 1122–1126.
Cheng, C.-K., Chang, K.-C., & Lee, Y.-J. (2009). Antiproliferative effect of beauvericin on retinoblastoma. 輔仁醫學期刊, 7(4), 161–169.
Daniel, J. F. S., Silva, A. A., Nakagawa, D. H., Medeiros, L. S. de, Carvalho, M. G., Tavares, L. J., Abreu, L. M., & Rodrigues-Filho, E. (2017). Larvicidal activity of Beauveria bassiana extracts against Aedes aegypti and identification of Beauvericins. Journal of the Brazilian Chemical Society, 28, 1003–1013.
Fukuda, T., Arai, M., Yamaguchi, Y., Masuma, R., Tomoda, H., & Omura, S. (2004). New Beauvericins, Potentiators of Antifungal Miconazole Activity, Produced by Beauveria sp. FKI-1366 I. Taxonomy, Fermentation, Isolation and Biological Properties. The Journal of Antibiotics, 57(2), 110–116.
Grove, J. F., & Pople, M. (1980). The insecticidal activity of beauvericin and the enniatin complex. Mycopathologia, 70(2), 103–105.
Hamill, R. L., Higgens, C. E., Boaz, H. E., & Gorman, M. (1969). The structure op beauvericin, a new depsipeptide antibiotic toxic to Artemia salina. Tetrahedron Letters, 10(49), 4255–4258.
Jow, G.-M., Chou, C.-J., Chen, B.-F., & Tsai, J.-H. (2004). Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium. Cancer Letters, 216(2), 165–173.
Kouri, K., Lemmens, M., & Lemmens-Gruber, R. (2003). Beauvericin-induced channels in ventricular myocytes and liposomes. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1609(2), 203–210.
Krska, R., Schuhmacher, R., Grasserbauer, M., & Scott, P. M. (1996). Determination of the Fusarium mycotoxin beauvericin at microgram/kg levels in corn by high-performance liquid chromatography with diode-array detection. Journal of Chromatography. A.
Lee, H.-S., Song, H.-H., Ahn, J.-H., Shin, C.-G., Lee, G.-P., & Lee, C. (2008). Statistical optimization of growth medium for the production of the entomopathogenic and phytotoxic cyclic depsipeptide beauvericin from Fusarium oxysporum KFCC 11363P. Journal of Microbiology and Biotechnology, 18(1), 138–144.
Leland, J. E., McGuire, M. R., Grace, J. A., Jaronski, S. T., Ulloa, M., Park, Y.-H., & Plattner, R. D. (2005). Strain selection of a fungal entomopathogen, Beauveria bassiana, for control of plant bugs (Lygus spp.)(Heteroptera: Miridae). Biological Control, 35(2), 104–114.
Lin, H.-I., Lee, Y.-J., Chen, B.-F., Tsai, M.-C., Lu, J.-L., Chou, C.-J., & Jow, G.-M. (2005). Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells. Cancer Letters, 230(2), 248–259.
Logrieco, A., Moretti, A., Castella, G., Kostecki, M., Golinski, P., Ritieni, A., & Chelkowski, J. (1998). Beauvericin production by Fusarium species. Applied and Environmental Microbiology, 64(8), 3084–3088.
Nilanonta, C., Isaka, M., Kittakoop, P., Trakulnaleamsai, S., Tanticharoen, M., & Thebtaranonth, Y. (2002). Precursor-directed biosynthesis of beauvericin analogs by the insect pathogenic fungus Paecilomyces tenuipes BCC 1614. Tetrahedron, 58(17), 3355–3360.
Ojcius, D. M., Zychlinsky, A., Zheng, L. M., & Young, J. D.-E. (1991). Ionophore-induced apoptosis: role of DNA fragmentation and calcium fluxes. Experimental Cell Research, 197(1), 43–49.
Plattner, R. D., & Nelson, P. E. (1994). Production of beauvericin by a strain of Fusarium proliferatum isolated from corn fodder for swine. Applied and Environmental Microbiology, 60(10), 3894–3896.
Que, F. G., Gores, G. J., & LaRusso, N. F. (1997). Development and initial application of an in vitro model of apoptosis in rodent cholangiocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology, 272(1), G106–G115.
Shekhar-Guturja, T., Gunaherath, G. M., Wijeratne, E. M., Lambert, J.-P., Averette, A. F., Lee, S. C., Kim, T., Bahn, Y.-S., Tripodi, F., & Ammar, R. (2016). Dual action antifungal small molecule modulates multidrug efflux and TOR signaling. Nature Chemical Biology, 12(10), 867–875.
Shin, C.-G., An, D.-G., Song, H.-H., & Lee, C. (2009). Beauvericin and enniatins H, I and MK1688 are new potent inhibitors of human immunodeficiency virus type-1 integrase. The Journal of Antibiotics, 62(12), 687–690.
Tong, Y., Liu, M., Zhang, Y., Liu, X., Huang, R., Song, F., Dai, H., Ren, B., Sun, N., & Pei, G. (2016). Beauvericin counteracted multi-drug resistant Candida albicans by blocking ABC transporters. Synthetic and Systems Biotechnology, 1(3), 158–168.
Wu, S.-N., Chen, H., Liu, Y.-C., & Chiang, H.-T. (2002). Block of L-type Ca2+ current by beauvericin, a toxic cyclopeptide, in the NG108-15 neuronal cell line. Chemical Research in Toxicology, 15(6), 854–860.
Xu, L.-J., Liu, Y.-S., Zhou, L.-G., & Wu, J.-Y. (2009). Enhanced beauvericin production with in situ adsorption in mycelial liquid culture of Fusarium redolens Dzf2. Process Biochemistry, 44(10), 1063–1067.
Xu, L.-J., Liu, Y.-S., Zhou, L.-G., & Wu, J.-Y. (2010). Optimization of a liquid medium for beauvericin production in Fusarium redolens Dzf2 mycelial culture. Biotechnology and Bioprocess Engineering, 15(3), 460–466.
Xu, L.-J., Liu, Y.-S., Zhou, L.-G., & Wu, J.-Y. (2011). Modeling of Fusarium redolens Dzf2 mycelial growth kinetics and optimal fed-batch fermentation for beauvericin production. Journal of Industrial Microbiology and Biotechnology, 38(9), 1187–1192.
Xu, L., Wang, J., Zhao, J., Li, P., Shan, T., Wang, J., Li, X., & Zhou, L. (2010). Beauvericin from the endophytic fungus, Fusarium redolens, isolated from Dioscorea zingiberensis and its antibacterial activity. Natural Product Communications, 5(5), 1934578X1000500527.
Zhan, J., Burns, A. M., Liu, M. X., Faeth, S. H., & Gunatilaka, A. A. L. (2007). Search for cell motility and angiogenesis inhibitors with potential anticancer activity: beauvericin and other constituents of two endophytic strains of Fusarium oxysporum. Journal of Natural Products, 70(2), 227–232.
Zhang, L., Yan, K., Zhang, Y., Huang, R., Bian, J., Zheng, C., Sun, H., Chen, Z., Sun, N., & An, R. (2007). High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences, 104(11), 4606–4611.